Ginkgo Bioworks Holdings, Inc. (DNA) Financials

DNA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 990.0 million 569.8 million
March 31, 2026 1.0 billion 589.9 million
Dec. 31, 2025 1.1 billion 611.1 million
Sept. 30, 2025 1.2 billion 629.4 million

DNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -46.9 million 7.6 million
March 31, 2026 -48.6 million 15.9 million
Dec. 31, 2025 -63.0 million 21.0 million
Sept. 30, 2025 -31.6 million 17.8 million

DNA Net Income

No data available :(

DNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 302.2 million - 404.1 million
March 31, 2026 373.5 million - 410.7 million
Dec. 31, 2025 422.6 million - 439.9 million
Sept. 30, 2025 461.9 million - 422.9 million

DNA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 62.1 million
March 31, 2026 59.6 million
Dec. 31, 2025 55.5 million
Sept. 30, 2025 55.6 million

DNA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.6 million 46.2 million 30.8 million -
March 31, 2026 1.9 million 49.9 million 37.8 million -
Dec. 31, 2025 15.3 million 50.1 million 46.0 million -
Sept. 30, 2025 7.7 million 69.4 million 45.0 million -

DNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 20.2 million 1.7 million
March 31, 2026 19.5 million 15.9 million
Dec. 31, 2025 33.4 million -8.2 million
Sept. 30, 2025 38.8 million 12.8 million

DNA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

DNA

Price: $6.79

52 week price:
5.37
17.58

Payout Ratio Range:
-1.56%
-0.26%

Earnings Per Share: -5.33 USD

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 21.0 million

Market Capitalization: 505.7 million

Links: